Skip to content
10-Q

Quarterly Report

CymaBay Therapeutics, Inc.

0001193125-23-272401

← back to feed
Filed
Nov 7, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 31, 2023 113.4M sh
Shares Diluted Q3 2023 · Sep 30, 2023 105.72M sh
Shares Diluted Q3 2023 · Sep 30, 2023 101.97M sh
Shares Diluted Q3 2023 · Sep 30, 2022 87.8M sh
Shares Diluted Q3 2023 · Sep 30, 2022 87.8M sh
Capex Q3 2023 · Sep 30, 2023 $265K
Capex Q3 2023 · Sep 30, 2022 $135K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$45.15M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$65.32M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $273.72M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $20.29M
Stockholders Equity Q3 2023 · Sep 30, 2023 $326.19M
Stockholders Equity Q3 2023 · Jun 30, 2023 $108.41M
Stockholders Equity Q3 2023 · Mar 31, 2023 $104.19M
Stockholders Equity Q3 2023 · Dec 31, 2022 $36.15M
Stockholders Equity Q3 2023 · Sep 30, 2022 $60.18M
Stockholders Equity Q3 2023 · Jun 30, 2022 $82.46M
Stockholders Equity Q3 2023 · Mar 31, 2022 $107.38M
Stockholders Equity Q3 2023 · Dec 31, 2021 $132.94M
Current Liabilities Q3 2023 · Sep 30, 2023 $19.67M
Current Liabilities Q3 2023 · Dec 31, 2022 $15.44M
Total Liabilities Q3 2023 · Sep 30, 2023 $124.86M
Total Liabilities Q3 2023 · Dec 31, 2022 $105.7M
Current Assets Q3 2023 · Sep 30, 2023 $447.66M
Current Assets Q3 2023 · Dec 31, 2022 $138.07M
Total Assets Q3 2023 · Sep 30, 2023 $451.05M
Total Assets Q3 2023 · Dec 31, 2022 $141.85M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.32
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.62
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.28
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.90
Eps Basic Q3 2023 · Sep 30, 2023 −$0.32
Eps Basic Q3 2023 · Sep 30, 2023 −$0.62
Eps Basic Q3 2023 · Sep 30, 2022 −$0.28
Eps Basic Q3 2023 · Sep 30, 2022 −$0.90
Sga Expense Q3 2023 · Sep 30, 2023 $12.25M
Sga Expense Q3 2023 · Sep 30, 2023 $32.15M
Sga Expense Q3 2023 · Sep 30, 2022 $5.9M
Sga Expense Q3 2023 · Sep 30, 2022 $17.87M
Rd Expense Q3 2023 · Sep 30, 2023 $19.96M
Rd Expense Q3 2023 · Sep 30, 2023 $58.05M
Rd Expense Q3 2023 · Sep 30, 2022 $15.46M
Rd Expense Q3 2023 · Sep 30, 2022 $51.77M
Net Income Q3 2023 · Sep 30, 2023 −$33.88M
Net Income Q3 2023 · Sep 30, 2023 −$63.47M
Net Income Q3 2023 · Jun 30, 2023 −$808K
Net Income Q3 2023 · Mar 31, 2023 −$28.78M
Net Income Q3 2023 · Sep 30, 2022 −$24.51M
Net Income Q3 2023 · Sep 30, 2022 −$79.37M
Net Income Q3 2023 · Jun 30, 2022 −$27.09M
Net Income Q3 2023 · Mar 31, 2022 −$27.77M
Operating Income Q3 2023 · Sep 30, 2023 −$32.21M
Operating Income Q3 2023 · Sep 30, 2023 −$59.18M
Operating Income Q3 2023 · Sep 30, 2022 −$21.36M
Operating Income Q3 2023 · Sep 30, 2022 −$69.63M
Stock Issued Q3 2023 · Sep 11, 2023 14.52M sh
Stock Issued Q3 2023 · Jan 23, 2023 11.82M sh